GDC-0853

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GDC-0853, covering 2019-09-10 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus [Phase 2]

See pricing